ETON PHARMACEUTICALS INC. - COMMON STOCK
17.34
02-May-25 16:45:00
15 minutes delayed
Stocks
+0.37
+2.18%
Today's range
16.85 - 17.49
ISIN
N/A
Source
NASDAQ
-
Eton Pharmaceuticals Reports Third Quarter Financial Results
15 Nov 2021 16:05:01 By Nasdaq GlobeNewswire
-
15 Nov 2021 06:30:00 By Nasdaq GlobeNewswire
-
08 Nov 2021 06:00:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021
03 Nov 2021 16:15:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Approved Orphan Drug Product Carglumic Acid
28 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Second Quarter Financial Results
16 Aug 2021 16:02:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
03 Aug 2021 16:05:02 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector
15 Jun 2021 16:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
15 Jun 2021 10:37:52 By Nasdaq GlobeNewswire
-
28 May 2021 08:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Record Revenue and Earnings
13 May 2021 16:05:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
04 May 2021 16:05:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
17 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
16 Mar 2021 16:02:00 By Nasdaq GlobeNewswire
-
04 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
16 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
08 Feb 2021 08:00:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14 Jan 2021 08:00:01 By Nasdaq GlobeNewswire